Proprietary AI analyst is now available
- Public Comps
- Fisher & Paykel
Fisher & Paykel Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fisher & Paykel and similar public comparables like Smith & Nephew, Penumbra, Olympus, Medpace and more.
Fisher & Paykel Overview
About Fisher & Paykel
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 27% in Europe, 21% in Asia-Pacific, and the remaining 10% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Founded
1969
HQ

Employees
7.5K
Website
Financials (LTM)
EV
$13B
Valuation Multiples
Start free trialFisher & Paykel Financials
Fisher & Paykel reported last 12-month revenue of $1B and EBITDA of $474M.
In the same LTM period, Fisher & Paykel generated $905M in gross profit, $474M in EBITDA, and $282M in net income.
Revenue (LTM)
Fisher & Paykel P&L
In the most recent fiscal year, Fisher & Paykel reported revenue of $1B and EBITDA of $470M.
Fisher & Paykel is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 35%, and net margin of 20%.
Financial data powered by Morningstar, Inc.
Fisher & Paykel Stock Performance
Fisher & Paykel has current market cap of $13B, and enterprise value of $13B.
Market Cap Evolution
Fisher & Paykel's stock price is $21.63.
Fisher & Paykel share price decreased by 3.1% in the last 30 days, and increased by 2.4% in the last year.
Fisher & Paykel has an EPS (earnings per share) of $0.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13B | $13B | -1.0% | -3.1% | -2.2% | 2.4% | $0.47 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFisher & Paykel Valuation Multiples
Fisher & Paykel trades at 9.1x EV/Revenue multiple, and 26.4x EV/EBITDA.
EV / Revenue (LTM)
Fisher & Paykel Financial Valuation Multiples
As of June 5, 2026, Fisher & Paykel has market cap of $13B and EV of $13B.
Fisher & Paykel has a P/E ratio of 45.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fisher & Paykel Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Fisher & Paykel Margins & Growth Rates
Fisher & Paykel grew revenue by 10% and EBITDA by 12% in the last fiscal year.
In the most recent fiscal year, Fisher & Paykel reported gross margin of 64%, EBITDA margin of 35%, and net margin of 20%.
Fisher & Paykel Margins
Fisher & Paykel Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Fisher & Paykel Operational KPIs
Fisher & Paykel's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Fisher & Paykel's Rule of 40 is 56% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fisher & Paykel's Rule of X is 88% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Fisher & Paykel Competitors
Fisher & Paykel competitors include Smith & Nephew, Penumbra, Olympus, Medpace, Cooper Companies, Align Technology, United Imaging, Zydus Lifesciences, Fresenius Medical Care and Coloplast.
Most Fisher & Paykel public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.5x | 2.4x | 9.7x | 9.3x | |||
| 8.7x | 8.2x | 46.7x | 44.0x | |||
| 2.1x | 2.0x | 9.0x | 11.7x | |||
| 5.0x | 4.8x | 22.3x | 21.6x | |||
| 3.5x | 3.4x | 11.3x | 10.8x | |||
| 2.8x | 2.7x | 10.3x | 9.9x | |||
| 6.1x | 5.7x | 33.3x | 32.4x | |||
| 4.2x | 4.1x | 13.5x | 15.8x | |||
This data is available for Pro users. Sign up to see all Fisher & Paykel competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fisher & Paykel
| When was Fisher & Paykel founded? | Fisher & Paykel was founded in 1969. |
| Where is Fisher & Paykel headquartered? | Fisher & Paykel is headquartered in New Zealand. |
| How many employees does Fisher & Paykel have? | As of today, Fisher & Paykel has over 7K employees. |
| Who is the CEO of Fisher & Paykel? | Fisher & Paykel's CEO is Lewis Gradon. |
| Is Fisher & Paykel publicly listed? | Yes, Fisher & Paykel is a public company listed on New Zealand Exchange. |
| What is the stock symbol of Fisher & Paykel? | Fisher & Paykel trades under FPH ticker. |
| When did Fisher & Paykel go public? | Fisher & Paykel went public in 1979. |
| Who are competitors of Fisher & Paykel? | Fisher & Paykel main competitors include Smith & Nephew, Penumbra, Olympus, Medpace, Cooper Companies, Align Technology, United Imaging, Zydus Lifesciences, Fresenius Medical Care, Coloplast. |
| What is the current market cap of Fisher & Paykel? | Fisher & Paykel's current market cap is $13B. |
| What is the current revenue of Fisher & Paykel? | Fisher & Paykel's last 12 months revenue is $1B. |
| What is the current revenue growth of Fisher & Paykel? | Fisher & Paykel revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Fisher & Paykel? | Current revenue multiple of Fisher & Paykel is 9.1x. |
| What is the current EBITDA of Fisher & Paykel? | Fisher & Paykel's last 12 months EBITDA is $474M. |
| What is Fisher & Paykel's EBITDA margin? | Fisher & Paykel's last 12 months EBITDA margin is 34%. |
| What is the current EV/EBITDA multiple of Fisher & Paykel? | Current EBITDA multiple of Fisher & Paykel is 26.4x. |
| What is the current FCF of Fisher & Paykel? | Fisher & Paykel's last 12 months FCF is $279M. |
| What is Fisher & Paykel's FCF margin? | Fisher & Paykel's last 12 months FCF margin is 20%. |
| What is the current EV/FCF multiple of Fisher & Paykel? | Current FCF multiple of Fisher & Paykel is 44.8x. |
| How many companies Fisher & Paykel has acquired to date? | Fisher & Paykel hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Fisher & Paykel has invested to date? | Fisher & Paykel hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Fisher & Paykel
Lists including Fisher & Paykel
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.